ARVI is an acronym that stands for Acute Respiratory Viral Infection. It is a term used in medical contexts to describe a range of viral infections affecting the respiratory system. ARVI refers to a group of illnesses caused by various viruses, including the common cold, influenza, and respiratory syncytial virus (RSV).
ARVI is characterized by symptoms such as coughing, sneezing, runny nose, sore throat, headache, and sometimes fever. These symptoms are usually mild to moderate and resolve on their own within a week or two. However, in some cases, especially among young children, older adults, and individuals with weakened immune systems, ARVI can lead to more severe respiratory complications, such as pneumonia or bronchitis.
The transmission of ARVI occurs through respiratory droplets from infected individuals. It can spread easily in crowded places, such as schools, workplaces, and public transportation. Proper hygiene measures, such as handwashing, covering the mouth and nose when coughing or sneezing, and avoiding close contact with infected individuals, are effective in preventing the spread of ARVI.
Treatment for ARVI involves primarily managing symptoms through rest, hydration, and over-the-counter medications to relieve discomfort. Antibiotics are not effective against viral infections, so they are not typically prescribed for ARVI unless there is a secondary bacterial infection. Vaccinations are available for specific strains of viral infections associated with ARVI, such as influenza, offering some protection against these specific viruses.
Overall, ARVI is a term used to describe viral respiratory infections, ranging from mild to moderate symptoms, with the potential for complications in certain populations.
